A.R.T. Advisors’s Ocera Therapeutics, Inc. OCRX Stock Holding History
Bought
Maintained
Sold
A.R.T. Advisors's OCRX Position: Q4 2017 in Review
A.R.T. Advisors sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 48,077 shares — an estimated $54K sold.
A.R.T. Advisors first reported a position in OCRX in Q2 2017 and held it in 2 quarters. The position peaked at $95K in Q2 2017. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.
- A.R.T. Advisors reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
- A.R.T. Advisors sold 48,077 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $54K.
- A.R.T. Advisors first reported a position in Ocera Therapeutics, Inc. in Q2 2017 and held it in 2 quarters.
- A.R.T. Advisors's Ocera Therapeutics, Inc. position peaked at $95K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.
Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.